nodes	percent_of_prediction	percent_of_DWPC	metapath
Levosimendan—Atrial fibrillation—Vemurafenib—melanoma	0.0206	0.0577	CcSEcCtD
Levosimendan—Haemoglobin decreased—Docetaxel—melanoma	0.0133	0.0372	CcSEcCtD
Levosimendan—Cardiac disorder—Vemurafenib—melanoma	0.0125	0.0351	CcSEcCtD
Levosimendan—Angiopathy—Vemurafenib—melanoma	0.0123	0.0343	CcSEcCtD
Levosimendan—Malnutrition—Vemurafenib—melanoma	0.0118	0.0329	CcSEcCtD
Levosimendan—Myocardial ischaemia—Docetaxel—melanoma	0.0114	0.0318	CcSEcCtD
Levosimendan—Nervous system disorder—Vemurafenib—melanoma	0.00942	0.0263	CcSEcCtD
Levosimendan—Hypokalaemia—Carmustine—melanoma	0.0094	0.0263	CcSEcCtD
Levosimendan—Hypokalaemia—Temozolomide—melanoma	0.00909	0.0254	CcSEcCtD
Levosimendan—Hypotension—Vemurafenib—melanoma	0.00897	0.0251	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Vemurafenib—melanoma	0.00829	0.0232	CcSEcCtD
Levosimendan—Constipation—Vemurafenib—melanoma	0.00821	0.023	CcSEcCtD
Levosimendan—Atrial fibrillation—Docetaxel—melanoma	0.00701	0.0196	CcSEcCtD
Levosimendan—Cardiac failure—Docetaxel—melanoma	0.0068	0.019	CcSEcCtD
Levosimendan—Diarrhoea—Vemurafenib—melanoma	0.00657	0.0184	CcSEcCtD
Levosimendan—Cardiac disorder—Temozolomide—melanoma	0.00641	0.0179	CcSEcCtD
Levosimendan—Dizziness—Vemurafenib—melanoma	0.00635	0.0178	CcSEcCtD
Levosimendan—Angiopathy—Temozolomide—melanoma	0.00627	0.0175	CcSEcCtD
Levosimendan—Mental disorder—Carmustine—melanoma	0.00626	0.0175	CcSEcCtD
Levosimendan—Malnutrition—Carmustine—melanoma	0.00622	0.0174	CcSEcCtD
Levosimendan—Vomiting—Vemurafenib—melanoma	0.0061	0.0171	CcSEcCtD
Levosimendan—Mental disorder—Temozolomide—melanoma	0.00605	0.0169	CcSEcCtD
Levosimendan—Headache—Vemurafenib—melanoma	0.00601	0.0168	CcSEcCtD
Levosimendan—Malnutrition—Temozolomide—melanoma	0.00601	0.0168	CcSEcCtD
Levosimendan—Nausea—Vemurafenib—melanoma	0.0057	0.016	CcSEcCtD
Levosimendan—Hypotension—Bleomycin—melanoma	0.00544	0.0152	CcSEcCtD
Levosimendan—Tachycardia—Carmustine—melanoma	0.00496	0.0139	CcSEcCtD
Levosimendan—Nervous system disorder—Temozolomide—melanoma	0.00481	0.0135	CcSEcCtD
Levosimendan—Hypotension—Carmustine—melanoma	0.00474	0.0133	CcSEcCtD
Levosimendan—Insomnia—Carmustine—melanoma	0.00459	0.0128	CcSEcCtD
Levosimendan—Insomnia—Temozolomide—melanoma	0.00444	0.0124	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Carmustine—melanoma	0.00438	0.0123	CcSEcCtD
Levosimendan—Constipation—Carmustine—melanoma	0.00434	0.0121	CcSEcCtD
Levosimendan—Cardiac disorder—Docetaxel—melanoma	0.00426	0.0119	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Temozolomide—melanoma	0.00424	0.0118	CcSEcCtD
Levosimendan—Constipation—Temozolomide—melanoma	0.0042	0.0117	CcSEcCtD
Levosimendan—Angiopathy—Docetaxel—melanoma	0.00417	0.0117	CcSEcCtD
Levosimendan—Mental disorder—Docetaxel—melanoma	0.00402	0.0113	CcSEcCtD
Levosimendan—Malnutrition—Docetaxel—melanoma	0.004	0.0112	CcSEcCtD
Levosimendan—Diarrhoea—Dactinomycin—melanoma	0.00371	0.0104	CcSEcCtD
Levosimendan—Vomiting—Bleomycin—melanoma	0.0037	0.0103	CcSEcCtD
Levosimendan—Diarrhoea—Carmustine—melanoma	0.00347	0.00972	CcSEcCtD
Levosimendan—Nausea—Bleomycin—melanoma	0.00346	0.00966	CcSEcCtD
Levosimendan—Vomiting—Dactinomycin—melanoma	0.00345	0.00965	CcSEcCtD
Levosimendan—Dizziness—Carmustine—melanoma	0.00336	0.00939	CcSEcCtD
Levosimendan—Diarrhoea—Temozolomide—melanoma	0.00336	0.00939	CcSEcCtD
Levosimendan—Dizziness—Temozolomide—melanoma	0.00324	0.00908	CcSEcCtD
Levosimendan—Vomiting—Carmustine—melanoma	0.00323	0.00903	CcSEcCtD
Levosimendan—Nausea—Dactinomycin—melanoma	0.00322	0.00901	CcSEcCtD
Levosimendan—Nervous system disorder—Docetaxel—melanoma	0.0032	0.00895	CcSEcCtD
Levosimendan—Tachycardia—Docetaxel—melanoma	0.00318	0.00891	CcSEcCtD
Levosimendan—Headache—Carmustine—melanoma	0.00318	0.0089	CcSEcCtD
Levosimendan—Vomiting—Temozolomide—melanoma	0.00312	0.00873	CcSEcCtD
Levosimendan—Headache—Temozolomide—melanoma	0.00307	0.0086	CcSEcCtD
Levosimendan—Hypotension—Docetaxel—melanoma	0.00305	0.00853	CcSEcCtD
Levosimendan—Nausea—Carmustine—melanoma	0.00302	0.00844	CcSEcCtD
Levosimendan—Insomnia—Docetaxel—melanoma	0.00295	0.00826	CcSEcCtD
Levosimendan—Nausea—Temozolomide—melanoma	0.00291	0.00815	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Docetaxel—melanoma	0.00282	0.00788	CcSEcCtD
Levosimendan—Constipation—Docetaxel—melanoma	0.00279	0.00781	CcSEcCtD
Levosimendan—PDE3A—Signaling by GPCR—CXCL1—melanoma	0.00232	0.00361	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—RAC2—melanoma	0.00229	0.00356	CbGpPWpGaD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—melanoma	0.00228	0.00355	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—MDM2—melanoma	0.00227	0.00353	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ACER3—melanoma	0.00226	0.00351	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—VEGFC—melanoma	0.00225	0.0035	CbGpPWpGaD
Levosimendan—Diarrhoea—Docetaxel—melanoma	0.00223	0.00625	CcSEcCtD
Levosimendan—PDE3A—GPCR downstream signaling—F2RL1—melanoma	0.00217	0.00338	CbGpPWpGaD
Levosimendan—Dizziness—Docetaxel—melanoma	0.00216	0.00604	CcSEcCtD
Levosimendan—PDE3A—Signaling Pathways—DRAP1—melanoma	0.00213	0.00331	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MYO7A—melanoma	0.00213	0.00331	CbGpPWpGaD
Levosimendan—Vomiting—Docetaxel—melanoma	0.00207	0.0058	CcSEcCtD
Levosimendan—KCNJ11—Metabolism—UGT2B10—melanoma	0.00207	0.00321	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GRM3—melanoma	0.00204	0.00318	CbGpPWpGaD
Levosimendan—Headache—Docetaxel—melanoma	0.00204	0.00572	CcSEcCtD
Levosimendan—PDE3A—Hemostasis—SPARC—melanoma	0.00198	0.00308	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—F2R—melanoma	0.00198	0.00308	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—F2RL1—melanoma	0.00197	0.00307	CbGpPWpGaD
Levosimendan—Nausea—Docetaxel—melanoma	0.00194	0.00542	CcSEcCtD
Levosimendan—PDE3A—GPCR downstream signaling—KISS1—melanoma	0.00194	0.00302	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HS3ST5—melanoma	0.00192	0.00299	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL6—melanoma	0.0019	0.00296	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CXCR1—melanoma	0.00188	0.00292	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GRM3—melanoma	0.00186	0.00289	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—HSPA5—melanoma	0.00185	0.00288	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—MC1R—melanoma	0.00185	0.00288	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TAS2R60—melanoma	0.00181	0.00282	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—GNA11—melanoma	0.00181	0.00281	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—GAB2—melanoma	0.00181	0.00281	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GRM1—melanoma	0.00177	0.00276	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CCR7—melanoma	0.00177	0.00276	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—KISS1—melanoma	0.00176	0.00274	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—PRKCA—melanoma	0.00174	0.00271	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CXCR1—melanoma	0.0017	0.00265	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—HDAC2—melanoma	0.0017	0.00264	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—GNAQ—melanoma	0.00168	0.00262	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—ITGA4—melanoma	0.00168	0.00262	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—CD44—melanoma	0.00168	0.00262	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—MC1R—melanoma	0.00168	0.00261	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IFNB1—melanoma	0.00167	0.0026	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IFNA1—melanoma	0.00163	0.00253	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—RHOB—melanoma	0.00161	0.00251	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GRM1—melanoma	0.00161	0.00251	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CCR7—melanoma	0.00161	0.00251	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—SYK—melanoma	0.00158	0.00246	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—MAPK1—melanoma	0.00155	0.00242	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—AKT3—melanoma	0.00155	0.00241	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—ITGAV—melanoma	0.00155	0.00241	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IFNA2—melanoma	0.00151	0.00236	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CXCR2—melanoma	0.00147	0.00229	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—RHOB—melanoma	0.00146	0.00228	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PLCB4—melanoma	0.00146	0.00226	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—RAC2—melanoma	0.00145	0.00225	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—ITGB1—melanoma	0.00141	0.00219	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PLCB4—melanoma	0.00137	0.00214	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCL1—melanoma	0.00137	0.00214	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SLC6A11—melanoma	0.00137	0.00213	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIP4K2A—melanoma	0.00137	0.00213	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CXCR2—melanoma	0.00133	0.00208	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—MTAP—melanoma	0.00133	0.00207	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—RAC2—melanoma	0.00131	0.00204	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—WNT5A—melanoma	0.00129	0.00201	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TRRAP—melanoma	0.00129	0.00201	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CUL3—melanoma	0.00129	0.00201	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—HGF—melanoma	0.00129	0.002	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—BRAF—melanoma	0.00128	0.002	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—CSF2—melanoma	0.00127	0.00198	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AKR1B10—melanoma	0.00125	0.00195	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—F2R—melanoma	0.00125	0.00194	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—HRAS—melanoma	0.00125	0.00194	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—ITGB3—melanoma	0.00122	0.0019	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PRKCA—melanoma	0.00122	0.0019	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—EDNRB—melanoma	0.00121	0.00188	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—LUM—melanoma	0.00119	0.00185	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PHGDH—melanoma	0.00119	0.00185	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—F2RL1—melanoma	0.00117	0.00182	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HPSE—melanoma	0.00116	0.00181	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GNA11—melanoma	0.00114	0.00178	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GAB2—melanoma	0.00114	0.00178	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CUBN—melanoma	0.00114	0.00178	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—F2R—melanoma	0.00113	0.00177	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—RAC1—melanoma	0.00113	0.00176	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SDHD—melanoma	0.0011	0.00172	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—BSG—melanoma	0.0011	0.00172	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CSPG4—melanoma	0.0011	0.00172	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—EDNRB—melanoma	0.0011	0.00171	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GRM3—melanoma	0.0011	0.00171	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—MMP1—melanoma	0.0011	0.0017	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—MDM2—melanoma	0.00108	0.00167	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—CDK2—melanoma	0.00107	0.00167	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CXCR4—melanoma	0.00107	0.00167	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GPAM—melanoma	0.00107	0.00166	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GNAQ—melanoma	0.00106	0.00165	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KISS1—melanoma	0.00104	0.00162	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GAB2—melanoma	0.00104	0.00161	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GNA11—melanoma	0.00104	0.00161	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SKI—melanoma	0.00101	0.00157	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCR1—melanoma	0.00101	0.00157	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—FN1—melanoma	0.000999	0.00156	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MC1R—melanoma	0.000992	0.00154	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—NOS2—melanoma	0.000987	0.00154	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AKT3—melanoma	0.00098	0.00153	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CXCR4—melanoma	0.000975	0.00152	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GNAQ—melanoma	0.000964	0.0015	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CG—melanoma	0.000956	0.00149	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCR7—melanoma	0.000951	0.00148	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GRM1—melanoma	0.000951	0.00148	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—EGF—melanoma	0.000945	0.00147	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SUFU—melanoma	0.000927	0.00144	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PLA2G6—melanoma	0.000908	0.00141	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—AKT3—melanoma	0.00089	0.00139	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IGF1—melanoma	0.000876	0.00136	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RHOB—melanoma	0.000865	0.00135	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—BCL2L11—melanoma	0.000865	0.00135	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CD—melanoma	0.000841	0.00131	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HDAC6—melanoma	0.000831	0.00129	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—ALB—melanoma	0.00083	0.00129	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—EDN1—melanoma	0.000823	0.00128	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—VCAN—melanoma	0.000816	0.00127	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CSF2—melanoma	0.000805	0.00125	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCR2—melanoma	0.000788	0.00123	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RAC2—melanoma	0.000775	0.00121	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PRKCA—melanoma	0.000772	0.0012	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—WNT5A—melanoma	0.000763	0.00119	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—VEGFC—melanoma	0.000763	0.00119	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—EDN1—melanoma	0.000748	0.00116	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—MAPK1—melanoma	0.000735	0.00114	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CB—melanoma	0.000733	0.00114	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CSF2—melanoma	0.000731	0.00114	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—RAC1—melanoma	0.000715	0.00111	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PRKCA—melanoma	0.000701	0.00109	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP17A1—melanoma	0.000688	0.00107	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—MAP2K2—melanoma	0.000685	0.00107	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IL2—melanoma	0.000673	0.00105	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—F2R—melanoma	0.00067	0.00104	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GNA11—melanoma	0.00065	0.00101	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—RAC1—melanoma	0.00065	0.00101	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EDNRB—melanoma	0.000649	0.00101	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—FASN—melanoma	0.000636	0.00099	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PTK2B—melanoma	0.00063	0.00098	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SLC5A5—melanoma	0.000626	0.000974	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GNA11—melanoma	0.000613	0.000954	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GAB2—melanoma	0.000613	0.000954	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FLT1—melanoma	0.00061	0.000949	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CG—melanoma	0.000604	0.000941	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GNAQ—melanoma	0.000604	0.00094	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CD44—melanoma	0.000604	0.00094	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—HRAS—melanoma	0.00059	0.000918	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP1B1—melanoma	0.000579	0.000902	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FOXO4—melanoma	0.000576	0.000897	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HDAC2—melanoma	0.000576	0.000897	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCR4—melanoma	0.000576	0.000897	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—VEGFA—melanoma	0.000572	0.00089	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GNAQ—melanoma	0.00057	0.000887	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—NRAS—melanoma	0.000565	0.000879	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CG—melanoma	0.000549	0.000854	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—MAPK3—melanoma	0.000541	0.000842	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SYK—melanoma	0.000536	0.000834	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CD—melanoma	0.000531	0.000827	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AKT3—melanoma	0.000526	0.000818	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NGFR—melanoma	0.000526	0.000818	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ITGAV—melanoma	0.000526	0.000818	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—MAPK1—melanoma	0.000515	0.000801	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SOCS1—melanoma	0.000487	0.000758	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—KRAS—melanoma	0.000486	0.000757	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—MAP2K1—melanoma	0.000486	0.000756	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—S100B—melanoma	0.000486	0.000756	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CD—melanoma	0.000482	0.000751	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ABCB1—melanoma	0.000477	0.000742	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ERBB4—melanoma	0.000464	0.000723	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CB—melanoma	0.000463	0.000721	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CDKN2B—melanoma	0.00046	0.000716	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CA—melanoma	0.000447	0.000695	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CD86—melanoma	0.000445	0.000693	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CXCL8—melanoma	0.000445	0.000693	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EDN1—melanoma	0.000442	0.000687	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PRKCA—melanoma	0.000439	0.000683	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ERCC2—melanoma	0.000435	0.000678	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—TP53—melanoma	0.000432	0.000673	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CSF2—melanoma	0.000432	0.000672	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGF1—melanoma	0.000432	0.000672	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—IL2—melanoma	0.000425	0.000662	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—E2F1—melanoma	0.000422	0.000658	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CB—melanoma	0.000421	0.000654	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PDGFRA—melanoma	0.000418	0.000651	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PRKCA—melanoma	0.000414	0.000644	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ITGB3—melanoma	0.000414	0.000644	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—HRAS—melanoma	0.000413	0.000643	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SPP1—melanoma	0.000406	0.000632	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MAP2K2—melanoma	0.000405	0.00063	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CXCL8—melanoma	0.000404	0.000629	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL2—melanoma	0.000386	0.000601	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TERT—melanoma	0.000385	0.000599	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RAC1—melanoma	0.000384	0.000597	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HIF1A—melanoma	0.000368	0.000573	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—AKT1—melanoma	0.000365	0.000568	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KDR—melanoma	0.000352	0.000548	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CG—melanoma	0.000344	0.000535	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FN1—melanoma	0.000339	0.000527	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PPARG—melanoma	0.000332	0.000517	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOTCH1—melanoma	0.000332	0.000516	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CD80—melanoma	0.000325	0.000505	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KIT—melanoma	0.000324	0.000505	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—APC—melanoma	0.000324	0.000505	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CG—melanoma	0.000324	0.000505	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—NRAS—melanoma	0.000324	0.000505	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EGF—melanoma	0.00032	0.000499	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—MAPK3—melanoma	0.00031	0.000483	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—BRAF—melanoma	0.000305	0.000474	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CD—melanoma	0.000302	0.00047	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ALB—melanoma	0.000298	0.000464	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IGF1—melanoma	0.000297	0.000462	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—MAPK1—melanoma	0.000295	0.00046	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—EGFR—melanoma	0.000295	0.00046	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MAP2K1—melanoma	0.000287	0.000447	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CD—melanoma	0.000285	0.000444	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CA—melanoma	0.000282	0.000439	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—KRAS—melanoma	0.000279	0.000434	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGF2—melanoma	0.000273	0.000425	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CB—melanoma	0.000263	0.00041	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PTGS2—melanoma	0.000261	0.000406	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CA—melanoma	0.000256	0.000399	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MDM2—melanoma	0.000255	0.000397	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ERBB2—melanoma	0.000252	0.000392	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CB—melanoma	0.000248	0.000387	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCL8—melanoma	0.000239	0.000372	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—HRAS—melanoma	0.000237	0.000369	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CDKN1B—melanoma	0.000233	0.000363	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AKT1—melanoma	0.000231	0.000359	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CASP3—melanoma	0.000228	0.000356	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL2—melanoma	0.000228	0.000355	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PTEN—melanoma	0.000228	0.000354	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL6—melanoma	0.000227	0.000353	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCND1—melanoma	0.000222	0.000346	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CTNNB1—melanoma	0.00022	0.000343	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MMP9—melanoma	0.000216	0.000336	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CDKN1A—melanoma	0.000215	0.000335	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PTEN—melanoma	0.000215	0.000334	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NFKB1—melanoma	0.000214	0.000332	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—AKT1—melanoma	0.000209	0.000326	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—VEGFA—melanoma	0.000194	0.000302	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—STAT3—melanoma	0.000192	0.000299	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NRAS—melanoma	0.000192	0.000298	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MAPK3—melanoma	0.000183	0.000285	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MYC—melanoma	0.000178	0.000278	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MAPK1—melanoma	0.000175	0.000272	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EGFR—melanoma	0.000174	0.000272	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KRAS—melanoma	0.000165	0.000257	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CA—melanoma	0.000161	0.00025	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CA—melanoma	0.000151	0.000236	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TP53—melanoma	0.000147	0.000228	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HRAS—melanoma	0.00014	0.000218	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL6—melanoma	0.000134	0.000209	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—AKT1—melanoma	0.000131	0.000204	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AKT1—melanoma	0.000124	0.000193	CbGpPWpGaD
